Hormonbehandlung bei Transgenderpatienten

@article{WinklerCrepaz2016HormonbehandlungBT,
  title={Hormonbehandlung bei Transgenderpatienten},
  author={K. Winkler-Crepaz and A. M{\"u}ller and B. B{\"o}ttcher and L. Wildt},
  journal={Gyn{\"a}kologische Endokrinologie},
  year={2016},
  volume={15},
  pages={39-42}
}
ZusammenfassungHintergrundDie gegengeschlechtliche Hormontherapie stellt einen wesentlichen Teil der Betreuung von Trans*Menschen dar. Ihr Ziel ist es, die sekundären Geschlechtsmerkmale des biologischen Geschlechts zu unterdrücken und jene des Wunschgeschlechts zu induzieren und aufrechtzuerhalten.FragestellungWelche Medikamente können zur gegengeschlechtlichen Hormontherapie angewandt werden und welche Effekte, Nebenwirkungen und Langzeitrisiken sind zu erwarten?Material und… Expand

References

SHOWING 1-10 OF 10 REFERENCES
Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist.
TLDR
It is concluded that cross-sex hormone treatment of male-to-female transsexuals using GnRHa and oestradiol-17beta valerate is effective, and side effects and complication rates can be reduced using the treatment regimen presented here. Expand
Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline.
TLDR
This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and the quality of evidence, which was low or very low. Expand
Endocrine treatment of transsexual persons : an Endocrine Society clinical practice guideline
Reproductive endocrinology is a wide field encompassing areas such as germ stem cell biology, assisted reproduction technologies, reproductive behavior, gonadal physiology, puberty, endocrineExpand
A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
TLDR
The increased mortality in hormone-treated MtF transsexuals was mainly due to non-hormone-related causes, but ethinyl estradiol may increase the risk of cardiovascular death, and use of testosterone in doses used for hypogonadal men seemed safe. Expand
Long-term evaluation of cross-sex hormone treatment in transsexual persons.
TLDR
Cross-sex hormone treatment appears to be safe in transsexual men, but a substantial number of transsexual women suffered from osteoporosis at the lumbar spine and distal arm, and more attention should be paid to decrease cardiovascular risk factors during hormone therapy management. Expand
Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
ABSTRACT The Standards of Care (SOC) for the Health of Transsexual, Transgender, and Gender Nonconforming People is a publication of the World Professional Association for Transgender Health (WPATH).Expand
Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals.
TLDR
There was an increase in lean mass during the study period in FtMs treated with testosterone undecanoate, and Transsexual patients should be monitored for adverse effects on lipid profiles, blood pressure, and erythrocytosis during intramuscular testosterone undECanoate therapy. Expand
RoefG,HeylensGetal (2012)Long-termevaluation of cross-sex hormone treatment in transsexual persons
  • 2012
A long - term follow - up study of mortality in transsexuals receivingtreatmentwithcrosssexhormones
  • EurJ Endocrinol
  • 2011
Dittrich R Effects of intramuscular testosterone undecanoate on body composition and bone mineral densitiy in femaleto male transsexuals
  • JSexMed
  • 2010